Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayne, M.
Right arrow Articles by Wang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayne, M.
Right arrow Articles by Wang, X.
Related Collections
Right arrow Animal models of human disease
Right arrow Neuroprotectors
Right arrow Gene therapy

(Stroke. 2001;32:240.)
© 2001 American Heart Association, Inc.


Original Contributions

Antisense Oligodeoxynucleotide Inhibition of Tumor Necrosis Factor-{alpha} Expression Is Neuroprotective After Intracerebral Hemorrhage

M. Mayne, PhD; W. Ni, MSc; H. J. Yan, MD; M. Xue, MD; J. B. Johnston, BSc; M. R. Del Bigio, MD, PhD; J. Peeling, PhD C. Power, MD

From the Departments of Pharmacology and Therapeutics (M.M., H.J.Y., J.P., C.P.) and Pathology (M.X., M.R.D.B.), University of Manitoba, Winnipeg, Manitoba, and Department of Clinical Neurosciences, Microbiology, and Infectious Diseases, University of Calgary, Calgary, Alberta (W.N., J.B.J., C.P.), Canada.

Correspondence to Dr C. Power, Department of Clinical Neurosciences, University of Calgary, HMRB 150, 3330 Hospital Dr, Calgary, AB T2N 4N1 Canada. E-mail power{at}ucalgary.ca

Background and Purpose—Tumor necrosis factor-{alpha} (TNF-{alpha}) expression is increased in brain after cerebral ischemia, although little is known about its abundance and role in intracerebral hemorrhage (ICH). A TNF-{alpha}–specific antisense oligodeoxynucleotide (ORF4-PE) was used to study the extent to which TNF-{alpha} expression influenced neurobehavioral outcomes and brain damage in a collagenase-induced ICH model in rat.

Methods—Male Sprague-Dawley rats were anesthetized, and ICH was induced by intrastriatal administration of heparin and collagenase. Immediately before or 3 hours after ICH induction, ORF4-PE was administered directly into the site of ICH. TNF-{alpha} mRNA and protein levels were measured by reverse transcriptase–polymerase chain reaction and immunoblot analyses. Cell death was measured by terminal deoxynucleotidyl transferase–mediated uridine 5'triphosphate-biotin nick end labeling (TUNEL). Neurobehavioral deficits were measured for 4 weeks after ICH.

Results—ICH induction (n=6) elevated TNF-{alpha} mRNA and protein levels (P<0.01) at 24 hours after the onset of injury compared with sham controls (n=6). Immunohistochemical labeling indicated that ICH was accompanied by elevated expression of TNF-{alpha} in neutrophils, macrophages, and microglia. Administration of ORF4-PE (2.0 nmol) directly into striatal parenchyma, 15 minutes before (n=4) or 3 hours after (n=6) ICH, decreased levels of TNF-{alpha} mRNA (P<0.001) and protein (P<0.01) in the brain tissue surrounding the hematoma compared with animals treated with saline alone (n=6). Mean±SEM striatal cell death (cells per high-powered field) was also reduced in animals receiving ORF4-PE (34.1±5.0) compared with the saline-treated ICH group (80.3±7.50) (P<0.001). ORF4-PE treatment improved neurobehavioral deficits observed at 24 hours (P<0.001) after induction of ICH (n=6) compared with the untreated ICH group (n=6). This improvement was maintained at 28 days after hemorrhage induction (P<0.001).

Conclusions—These results indicate a pathogenic role for TNF-{alpha} during ICH and demonstrate that reducing TNF-{alpha} expression using antisense oligodeoxynucleotides is neuroprotective.

Editorial Comment

Giora Z. Feuerstein, MD, Guest Editor; Siew Ho, MD, Guest Editor Xinkang Wang, MD, Guest Editor

Cardiovascular Sciences, DuPont Pharmaceuticals Company, Wilmington, Delaware




This article has been cited by other articles:


Home page
FASEB J.Home page
S. Tsutsui, D. Vergote, N. Shariat, K. Warren, S. S. G. Ferguson, and C. Power
Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and {beta}-arrestin-1 in monocytoid cells
FASEB J, March 1, 2008; 22(3): 786 - 796.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X. Zhao, G. Sun, J. Zhang, R. Strong, P. K. Dash, Y. W. Kan, J. C. Grotta, and J. Aronowski
Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Stroke, December 1, 2007; 38(12): 3280 - 3286.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K.-H. Jung, K. Chu, S.-T. Lee, S.-J. Kim, E.-C. Song, E.-H. Kim, D.-K. Park, D.-I. Sinn, J.-M. Kim, M. Kim, et al.
Blockade of AT1 Receptor Reduces Apoptosis, Inflammation, and Oxidative Stress in Normotensive Rats with Intracerebral Hemorrhage
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1051 - 1058.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. D. Ardizzone, X. Zhan, B. P. Ander, and F. R. Sharp
Src Kinase Inhibition Improves Acute Outcomes After Experimental Intracerebral Hemorrhage
Stroke, May 1, 2007; 38(5): 1621 - 1625.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-C. Lee, G.-S. Cho, B.-O. Choi, H. Chun Kim, Y.-S. Kim, and W.-K. Kim
Intracerebral Hemorrhage-Induced Brain Injury Is Aggravated in Senescence-Accelerated Prone Mice
Stroke, January 1, 2006; 37(1): 216 - 222.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Wang and S. E. Tsirka
Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage
Brain, July 1, 2005; 128(7): 1622 - 1633.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K.-H. Jung, K. Chu, S.-W. Jeong, S.-Y. Han, S.-T. Lee, J.-Y. Kim, M. Kim, and J.-K. Roh
HMG-CoA Reductase Inhibitor, Atorvastatin, Promotes Sensorimotor Recovery, Suppressing Acute Inflammatory Reaction After Experimental Intracerebral Hemorrhage
Stroke, July 1, 2004; 35(7): 1744 - 1749.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Zhao and R. D. Brinton
Suppression of Proinflammatory Cytokines Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} in Astrocytes by a V1 Vasopressin Receptor Agonist: A cAMP Response Element-Binding Protein-Dependent Mechanism
J. Neurosci., March 3, 2004; 24(9): 2226 - 2235.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. M. P. Rodrigues, S. Sola, Z. Nan, R. E. Castro, P. S. Ribeiro, W. C. Low, and C. J. Steer
Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats
PNAS, May 13, 2003; 100(10): 6087 - 6092.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X. Wang, T. Mori, T. Sumii, and E. H. Lo
Hemoglobin-Induced Cytotoxicity in Rat Cerebral Cortical Neurons: Caspase Activation and Oxidative Stress
Stroke, July 1, 2002; 33(7): 1882 - 1888.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Xue and M. R. Del Bigio
Acute Tissue Damage After Injections of Thrombin and Plasmin into Rat Striatum
Stroke, September 1, 2001; 32(9): 2164 - 2169.
[Abstract] [Full Text] [PDF]